Literature DB >> 3309954

A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer.

E R Barrack1, D J Tindall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3309954

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  6 in total

Review 1.  Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.

Authors:  D A Mankoff; F Dehdashti; A F Shields
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Androgen receptor gene mutations in human prostate cancer.

Authors:  J R Newmark; D O Hardy; D C Tonb; B S Carter; J I Epstein; W B Isaacs; T R Brown; E R Barrack
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 3.  Androgen receptor gene mutations in prostate cancer. Implications for disease progression and therapy.

Authors:  Z Culig; A Hobisch; A Hittmair; M V Cronauer; C Radmayr; G Bartsch; H Klocker
Journal:  Drugs Aging       Date:  1997-01       Impact factor: 3.923

4.  Computer based receptogram approach: an objective way of assessing immunohistochemistry of androgen receptor staining and its correlation with hormonal response in metastatic carcinoma of prostate.

Authors:  G Nabi; A Seth; A K Dinda; N P Gupta
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

5.  Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.

Authors:  J A Ruizeveld de Winter; P J Janssen; H M Sleddens; M C Verleun-Mooijman; J Trapman; A O Brinkmann; A B Santerse; F H Schröder; T H van der Kwast
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

6.  Immunocytochemical assay for androgen receptors in prostate cancer: a prospective study of 63 cases with long-term follow-up.

Authors:  L P Pertschuk; R J Macchia; J G Feldman; K A Brady; M Levine; D S Kim; K B Eisenberg; E Rainford; G S Prins; G L Greene
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.